Walleye Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

Walleye Trading’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-368,443	Closed	-$2.22M	–	4909
2019 Q4	$2.22M	Buy	+368,443	New	+$2.13M	0.02%	1150
2018 Q1	–	Sell	-45,600	Closed	-$131K	–	4963
2017 Q4	$131K	Buy	+45,600	New	+$166K	﹤0.01%	3708
2016 Q1	–	Sell	-1,638	Closed	-$18K	–	6061
2015 Q4	$18K	Buy	+1,638	New	+$14.9K	﹤0.01%	4496
2015 Q3	–	Sell	-300	Closed	-$3K	–	5740
2015 Q2	$3K	Buy	+300	New	+$2.84K	﹤0.01%	4644

Walleye Trading's ACHN Position: Q1 2020 in Review

Walleye Trading sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 368,443 shares — an estimated $2.22M sold.

Walleye Trading first reported a position in ACHN in Q2 2015 and held it in 4 quarters. The position peaked at $2.22M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Walleye Trading reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Walleye Trading sold 368,443 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.22M.
Walleye Trading first reported a position in Achillion Pharmaceuticals in Q2 2015 and held it in 4 quarters.
Walleye Trading's Achillion Pharmaceuticals position peaked at $2.22M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.